Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting

Sudheesh Pilakka-Kanthikeel, Kristopher Arheart, Anbalagan Selvaraj, Soumya Swaminathan, Savita G Pahwa

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

BACKGROUND: Gut damage resulting in microbial translocation (MT) is considered a major cause of immune activation (IA) in HIV infection, but data in children are limited, particularly in the absence of antiretroviral therapy. METHODS: Sixty perinatally HIV-infected, antiretroviral therapy-naive children, aged 2-12 years, were evaluated for plasma levels of lipopolysaccharide, DNA sequences encoding bacterial 16 second ribosomal DNA (16S rDNA) and soluble CD14 concurrently with markers of CD4 and CD8 T-cell IA and immune exhaustion (IE), CD4 counts, and plasma viral load. At study entry, participants were classified into immune categories (ICs): IC1 (CD4% > 25), IC2 (CD4% 15-25), and IC3 (CD4% < 15). Age-matched HIV-uninfected children served as controls. Data were evaluated at study entry and at 12 months. RESULTS: Levels of MT, IA, and IE were increased in patients as compared with controls, were highest in patients in IC3 group, and did not change over 12 months. MT products lipopolysaccharide and 16S rDNA correlated with each other and each correlated with plasma viral load, soluble CD14, and T-cell IA and IE. There was a correlation of IA with IE. CD4 counts and percentage were inversely correlated with MT products and underlying CD4 activation. CONCLUSIONS: In a natural history cohort of HIV-infected children not on therapy, MT was more pronounced in the most severely immunocompromised patients and was associated with IA. Strategies to reduce MT may help to reduce IA and prevent CD4 depletion.

Original languageEnglish
Pages (from-to)16-24
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume66
Issue number1
DOIs
StatePublished - May 1 2014

Fingerprint

HIV
CD4 Lymphocyte Count
Ribosomal DNA
Viral Load
Lipopolysaccharides
T-Lymphocytes
Immunocompromised Host
Therapeutics
Natural History
HIV Infections

Keywords

  • 16S rDNA
  • HIV-infected children
  • LPS
  • microbial translocation

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting. / Pilakka-Kanthikeel, Sudheesh; Arheart, Kristopher; Selvaraj, Anbalagan; Swaminathan, Soumya; Pahwa, Savita G.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 66, No. 1, 01.05.2014, p. 16-24.

Research output: Contribution to journalArticle

@article{5ccf05940b3140689aaa4dfbf43bfa78,
title = "Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting",
abstract = "BACKGROUND: Gut damage resulting in microbial translocation (MT) is considered a major cause of immune activation (IA) in HIV infection, but data in children are limited, particularly in the absence of antiretroviral therapy. METHODS: Sixty perinatally HIV-infected, antiretroviral therapy-naive children, aged 2-12 years, were evaluated for plasma levels of lipopolysaccharide, DNA sequences encoding bacterial 16 second ribosomal DNA (16S rDNA) and soluble CD14 concurrently with markers of CD4 and CD8 T-cell IA and immune exhaustion (IE), CD4 counts, and plasma viral load. At study entry, participants were classified into immune categories (ICs): IC1 (CD4{\%} > 25), IC2 (CD4{\%} 15-25), and IC3 (CD4{\%} < 15). Age-matched HIV-uninfected children served as controls. Data were evaluated at study entry and at 12 months. RESULTS: Levels of MT, IA, and IE were increased in patients as compared with controls, were highest in patients in IC3 group, and did not change over 12 months. MT products lipopolysaccharide and 16S rDNA correlated with each other and each correlated with plasma viral load, soluble CD14, and T-cell IA and IE. There was a correlation of IA with IE. CD4 counts and percentage were inversely correlated with MT products and underlying CD4 activation. CONCLUSIONS: In a natural history cohort of HIV-infected children not on therapy, MT was more pronounced in the most severely immunocompromised patients and was associated with IA. Strategies to reduce MT may help to reduce IA and prevent CD4 depletion.",
keywords = "16S rDNA, HIV-infected children, LPS, microbial translocation",
author = "Sudheesh Pilakka-Kanthikeel and Kristopher Arheart and Anbalagan Selvaraj and Soumya Swaminathan and Pahwa, {Savita G}",
year = "2014",
month = "5",
day = "1",
doi = "10.1097/QAI.0000000000000096",
language = "English",
volume = "66",
pages = "16--24",
journal = "Journal of acquired immune deficiency syndromes (1999)",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "1",

}

TY - JOUR

T1 - Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting

AU - Pilakka-Kanthikeel, Sudheesh

AU - Arheart, Kristopher

AU - Selvaraj, Anbalagan

AU - Swaminathan, Soumya

AU - Pahwa, Savita G

PY - 2014/5/1

Y1 - 2014/5/1

N2 - BACKGROUND: Gut damage resulting in microbial translocation (MT) is considered a major cause of immune activation (IA) in HIV infection, but data in children are limited, particularly in the absence of antiretroviral therapy. METHODS: Sixty perinatally HIV-infected, antiretroviral therapy-naive children, aged 2-12 years, were evaluated for plasma levels of lipopolysaccharide, DNA sequences encoding bacterial 16 second ribosomal DNA (16S rDNA) and soluble CD14 concurrently with markers of CD4 and CD8 T-cell IA and immune exhaustion (IE), CD4 counts, and plasma viral load. At study entry, participants were classified into immune categories (ICs): IC1 (CD4% > 25), IC2 (CD4% 15-25), and IC3 (CD4% < 15). Age-matched HIV-uninfected children served as controls. Data were evaluated at study entry and at 12 months. RESULTS: Levels of MT, IA, and IE were increased in patients as compared with controls, were highest in patients in IC3 group, and did not change over 12 months. MT products lipopolysaccharide and 16S rDNA correlated with each other and each correlated with plasma viral load, soluble CD14, and T-cell IA and IE. There was a correlation of IA with IE. CD4 counts and percentage were inversely correlated with MT products and underlying CD4 activation. CONCLUSIONS: In a natural history cohort of HIV-infected children not on therapy, MT was more pronounced in the most severely immunocompromised patients and was associated with IA. Strategies to reduce MT may help to reduce IA and prevent CD4 depletion.

AB - BACKGROUND: Gut damage resulting in microbial translocation (MT) is considered a major cause of immune activation (IA) in HIV infection, but data in children are limited, particularly in the absence of antiretroviral therapy. METHODS: Sixty perinatally HIV-infected, antiretroviral therapy-naive children, aged 2-12 years, were evaluated for plasma levels of lipopolysaccharide, DNA sequences encoding bacterial 16 second ribosomal DNA (16S rDNA) and soluble CD14 concurrently with markers of CD4 and CD8 T-cell IA and immune exhaustion (IE), CD4 counts, and plasma viral load. At study entry, participants were classified into immune categories (ICs): IC1 (CD4% > 25), IC2 (CD4% 15-25), and IC3 (CD4% < 15). Age-matched HIV-uninfected children served as controls. Data were evaluated at study entry and at 12 months. RESULTS: Levels of MT, IA, and IE were increased in patients as compared with controls, were highest in patients in IC3 group, and did not change over 12 months. MT products lipopolysaccharide and 16S rDNA correlated with each other and each correlated with plasma viral load, soluble CD14, and T-cell IA and IE. There was a correlation of IA with IE. CD4 counts and percentage were inversely correlated with MT products and underlying CD4 activation. CONCLUSIONS: In a natural history cohort of HIV-infected children not on therapy, MT was more pronounced in the most severely immunocompromised patients and was associated with IA. Strategies to reduce MT may help to reduce IA and prevent CD4 depletion.

KW - 16S rDNA

KW - HIV-infected children

KW - LPS

KW - microbial translocation

UR - http://www.scopus.com/inward/record.url?scp=84898547210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898547210&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000000096

DO - 10.1097/QAI.0000000000000096

M3 - Article

C2 - 24378729

AN - SCOPUS:84898547210

VL - 66

SP - 16

EP - 24

JO - Journal of acquired immune deficiency syndromes (1999)

JF - Journal of acquired immune deficiency syndromes (1999)

SN - 1525-4135

IS - 1

ER -